p53 mutant has designated as a gain-of-oncogenic function(s) (GOFs) which improved cell migration, proliferation, as well as invasion with anti-apoptotic functions which dynamically contribute to numerous phases of tumor progression in cancer (Dittmer et al., 1993; Oren and Rotter, 2010). Here, TP53 is linked to cancer.